Ioannou, G. N., Berry, K., Rajeevan, N., Li, Y., Mutalik, P., Yan, L., … Bajema, K. L. (2023). Effectiveness of Nirmatrelvir-Ritonavir Against the Development of Post-COVID-19 Conditions Among US Veterans A Target Trial Emulation. ANNALS OF INTERNAL MEDICINE, 176(11), 1486–1497.

Ioannou, George N., Kristin Berry, Nallakkandi Rajeevan, Yuli Li, Pradeep Mutalik, Lei Yan, David Bui, et al. “Effectiveness of Nirmatrelvir-Ritonavir Against the Development of Post-COVID-19 Conditions Among US Veterans A Target Trial Emulation.” ANNALS OF INTERNAL MEDICINE 176, no. 11 (2023): 1486–97.

Ioannou GN, Berry K, Rajeevan N, Li Y, Mutalik P, Yan L, et al. Effectiveness of Nirmatrelvir-Ritonavir Against the Development of Post-COVID-19 Conditions Among US Veterans A Target Trial Emulation. ANNALS OF INTERNAL MEDICINE. 2023;176(11):1486–97.

Ioannou, George N., et al. “Effectiveness of Nirmatrelvir-Ritonavir Against the Development of Post-COVID-19 Conditions Among US Veterans A Target Trial Emulation.” ANNALS OF INTERNAL MEDICINE, vol. 176, no. 11, 2023, pp. 1486–97.

Ioannou GN, Berry K, Rajeevan N, Li Y, Mutalik P, Yan L, Bui D, Cunningham F, Hynes DM, Rowneki M, Bohnert A, Boyko EJ, Iwashyna TJ, Maciejewski ML, Osborne TF, Viglianti EM, Aslan M, Huang GD, Bajema KL. Effectiveness of Nirmatrelvir-Ritonavir Against the Development of Post-COVID-19 Conditions Among US Veterans A Target Trial Emulation. ANNALS OF INTERNAL MEDICINE. 2023;176(11):1486–1497.